Condition
Acute Pulmonary Edema
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed3
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02856698Phase 4TerminatedPrimary
MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)
NCT03607201Completed
Acute Coronary Syndrome in Diabetic Patients
NCT03596931Completed
Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients
NCT02880358Unknown
Epidemiology and Prognostic of the Acute Heart Failure
NCT01455766Completed
Volumetric Monitoring in Major Lung Surgery
Showing all 5 trials